AIM
ACAD icon

Allen Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Allen Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-414,459
Closed -$13.5M – 210
2015
Q1 		$13.5M Buy
414,459
+114,459
+38% +$3.93M 0.99% 40
2014
Q4 		$9.53M Buy
+300,000
New +$8.51M 0.72% 42

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Allen Investment Management's ACAD Position: Q2 2015 in Review

Allen Investment Management sold out of Acadia Pharmaceuticals (ACAD) in Q2 2015, closing a stake of 414,459 shares — an estimated $13.5M sold.

Allen Investment Management first reported a position in ACAD in Q4 2014 and held it in 2 quarters. The position peaked at $13.5M in Q1 2015. 188 funds tracked by Wall St. Rank hold ACAD as of Q2 2015.

  • Allen Investment Management reported no remaining Acadia Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Allen Investment Management sold 414,459 Acadia Pharmaceuticals shares in Q2 2015, an estimated $13.5M.
  • Allen Investment Management first reported a position in Acadia Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Allen Investment Management's Acadia Pharmaceuticals position peaked at $13.5M in Q1 2015.
  • 188 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2015.

Based on Allen Investment Management's 13F filing for Q2 2015, filed 14 Aug 2015.